OC-0625 LDR monotherapy versus LDR boost for intermediate-risk prostate cancer: long-term outcomes

Autor: Goni Ramirez, A., De Paula, B., Saenz de Urturi, E., Pastor Sanchis, V., Bartres, A., Egiguren, M., Pagola, M., Roura, D.A., Ayete, A., Palacios, S., Iceta, U., Gonzalez, L., Ortiz de Urbina, D.I., Alba, V., Erzilbengoa, M., Rosa Nieto, J.
Zdroj: In Radiotherapy and Oncology May 2023 182 Supplement 1:S515-S516
Databáze: ScienceDirect